Journal
JOURNAL OF THORACIC DISEASE
Volume 9, Issue 4, Pages 936-939Publisher
AME PUBL CO
DOI: 10.21037/jtd.2017.03.10
Keywords
-
Categories
Funding
- Anthera
- AstraZeneca
- Amgen
- Cerenis
- Eli Lilly
- Novartis
- Resverlogix
- Sanofi-Regeneron